# HEATR6

## Overview
HEATR6, or HEAT repeat containing 6, is a gene that encodes a protein characterized by the presence of HEAT repeats, which are tandemly repeated sequences often involved in intracellular transport and protein-protein interactions. The HEATR6 protein is implicated in various cellular processes, including cell cycle regulation and DNA repair, which are critical for maintaining genomic stability. Its role in these processes suggests that HEATR6 may function as a regulatory protein, potentially influencing cell division and response to DNA damage. The gene's expression has been associated with several types of cancer, including breast, gastric, and brain carcinomas, where it is often overexpressed, indicating a possible role in tumor progression and as a prognostic marker (Quimbaya2012Identification). Further research is needed to elucidate the precise molecular mechanisms by which HEATR6 influences cancer biology and its potential as a therapeutic target.

## Clinical Significance
HEATR6 has been implicated in various cancers due to its role in cell cycle regulation and potential involvement in DNA repair processes. In breast epithelial cancer cell cultures, the knockdown of HEATR6 led to a noticeable effect on cell culture growth, suggesting a potential cell cycle arrest at the G2/M phase. This indicates that HEATR6 may play a significant role in cell cycle control, which is crucial in cancer biology (Quimbaya2012Identification). HEATR6 is located on a commonly amplified fragment in breast cancer and is overexpressed in gastric, brain, and breast carcinomas, suggesting its involvement in cancer progression (Quimbaya2012Identification).

In endometrioid endometrial cancer (EEC), HEATR6 has been identified as significantly altered in black patients, with a potential impact on progression-free survival. This suggests that HEATR6 may contribute to differential disease outcomes and could be a prognostic marker in this specific cohort (Bateman2017Race‐specific). The gene's expression and its association with cancer progression highlight its clinical significance and potential as a target for therapeutic interventions. However, the full extent of its molecular interactions and clinical implications requires further investigation.


## References


[1. (Quimbaya2012Identification) Mauricio Quimbaya, Klaas Vandepoele, Eric Raspé, Michiel Matthijs, Stijn Dhondt, Gerrit T. S. Beemster, Geert Berx, and Lieven De Veylder. Identification of putative cancer genes through data integration and comparative genomics between plants and humans. Cellular and Molecular Life Sciences, 69(12):2041–2055, January 2012. URL: http://dx.doi.org/10.1007/s00018-011-0909-x, doi:10.1007/s00018-011-0909-x. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-011-0909-x)

[2. (Bateman2017Race‐specific) Nicholas W. Bateman, Elizabeth A. Dubil, Guisong Wang, Brian L. Hood, Julie M. Oliver, Tracy A. Litzi, Glenn D. Gist, David A. Mitchell, Brian Blanton, Neil T. Phippen, Chunqiao Tian, Christopher M. Zahn, David E. Cohn, Laura J. Havrilesky, Andrew Berchuck, Craig D. Shriver, Kathleen M. Darcy, Chad A. Hamilton, Thomas P. Conrads, and G. Larry Maxwell. Race‐specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer, 123(20):4004–4012, June 2017. URL: http://dx.doi.org/10.1002/cncr.30813, doi:10.1002/cncr.30813. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/cncr.30813)